Frequent Amplification of C-erbB2 (HER-2/Neu) Oncogene in Cervical Carcinoma as Detected by Non-Fluorescence in situ Hybridization Technique on Paraffin Sections

Publisher： Karger

E-ISSN： 1423-0232|56|1|83-87

ISSN： 0030-2414

Source： Oncology, Vol.56, Iss.1, 1999-01, pp. : 83-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Negative Prognostic Impact of the Coexpression of Epidermal Growth Factor Receptor and c-erbB-2 in Locally Advanced Cervical Cancer

By  

Oncology, Vol. 76, Iss. 2, 2009-01 ,pp. : 133-141

Karger

Access to resources Recommend Favorite

Impact of the 2013 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing of invasive breast carcinoma: a focus on tumours assessed as ‘equivocal’ for HER2 gene amplification by fluorescence in‐situ hybridization

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 880-887

John Wiley & Sons Inc

Access to resources Recommend Favorite

Amplification of the c-met, c-erbB-2 and Epidermal Growth Factor Receptor Gene in Human Gastric Cancers: Correlation to Clinical Features

By  

Oncology, Vol. 55, Iss. 5, 1998-08 ,pp. : 475-481

Karger

Access to resources Recommend Favorite

Cytoplasmic Expression of c-erb-B2 in Endometrial Carcinomas

By  

Oncology Research and Treatment, Vol. 30, Iss. 10, 2007-09 ,pp. : 495-500

Karger

Access to resources Recommend Favorite

In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors

By  

GENES, CHROMOSOMES AND CANCER, Vol. 57, Iss. 4, 2018-04 ,pp. : 182-191

John Wiley & Sons Inc

Access to resources Recommend Favorite